IGXT's logo.
Ticker Symbol: IGXT

IntelGenx Technologies Corp

Exchange: OTC MARKETS Country: Canada Currency: USD Asset Type: Common Stock CIK:0001098880

Company Profile

intelgenx is a montreal based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery. our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and safety and, in conjunction with strategic development and distribution partners, reintroduce these drug compounds to the market as branded products with improved deliverability and efficacy. intelgenx is capable, through itself and strategic partners, of offering its partners full service pharmaceutical development from formulation development, clinical development and regulatory activities to manufacturing and packaging. intelgenx’s highly qualified team has the capability to work with new chemical entities (nces) or established therapeutic active pharmaceutical ingredients (apis) where the use of innovative new drug delivery systems offer significant competitive advantage or the opportunity for product exten

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 6420 Abrams St
CEO: Horst Zerbe
Tags:
  • Pharmaceuticals: Other
  • Health Technology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.12
Change: $0.00 ( -2.74%)
Days Range: $0.12 - $0.13
Beta: -
52wk. High: $0.27
52wk. Low: $0.10
Ytd. Change -36.25%
50 Day Moving Average: $0.13
200 Day Moving Average: $0.16
Shares Outstanding: 174658097

Valuation

Market Cap: 2.2B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A